KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Depreciation and Depletion: 2011-2024

Historic Depreciation and Depletion for Esperion Therapeutics (ESPR) over the last 14 years, with Dec 2024 value amounting to $100,000.

  • Esperion Therapeutics' Depreciation and Depletion changed negligibly% to $26,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $143,000, marking a year-over-year increase of 37.50%. This contributed to the annual value of $100,000 for FY2024, which is 50.00% down from last year.
  • Per Esperion Therapeutics' latest filing, its Depreciation and Depletion stood at $100,000 for FY2024, which was down 50.00% from $200,000 recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Depreciation and Depletion registered a high of $612,000 during FY2021, and its lowest value of $100,000 during FY2024.
  • In the last 3 years, Esperion Therapeutics' Depreciation and Depletion had a median value of $200,000 in 2023 and averaged $266,667.
  • Per our database at Business Quant, Esperion Therapeutics' Depreciation and Depletion surged by 71.47% in 2020 and then plummeted by 60.00% in 2023.
  • Over the past 5 years, Esperion Therapeutics' Depreciation and Depletion (Yearly) stood at $547,000 in 2020, then rose by 11.88% to $612,000 in 2021, then fell by 18.30% to $500,000 in 2022, then slumped by 60.00% to $200,000 in 2023, then slumped by 50.00% to $100,000 in 2024.